Adherence to aspirin
Aspirin → Adherence to aspirin
Aspirin → Adherence to aspirin
Evidence profile
Key finding
7312 (47.2%) participants were fully adherent to aspirin.
The ASCEND study investigated cardiovascular events in diabetic participants through a randomized controlled trial involving aspirin and omega-3 fatty acid supplementation.
Evidence strength
Moderate confidence
Study type
RCTs
Follow-up
Extended (5–20+ y)
Quick read
The essential study design details in one scan.
Population
Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes
Intervention
Aspirin, Placebo, Omega-3 Fatty Acid Supplementation, Placebo for Omega-3
Study type
RCTs
Follow-up
Extended (5–20+ y)
Primary outcome
Adherence to Aspirin
Comparator
Placebo for Aspirin, Placebo for Omega-3
Plain-language summary
A plain-language read of the study's main message and where it applies.
Study focus
The ASCEND study investigated cardiovascular events in diabetic participants through a randomized controlled trial involving aspirin and omega-3 fatty acid supplementation.
Understanding adherence rates and predictors is crucial for improving treatment strategies in diabetic patients at risk for cardiovascular events. This study highlights the need for targeted interventions to enhance adherence, which can ultimately lead to better health outcomes.
Effectiveness of interventions remains unclear. Adherence rates may not reflect long-term outcomes. Generalizability may be limited to specific diabetic populations.
Published in
Publication details and source links for this paper.
Vichithranie WM, Marion M, Georgina B, Louise B, Jane A. ASCEND: A Study of Cardiovascular Events in Diabetes. Trials. 2026;27:183. doi:10.1186/s13063-026-09551-4
Save this study and add notes to your research library.
7312 participants (47.2%) were fully adherent to aspirin.
8937 participants (57.7%) were fully adherent to omega-3.
Adherence decreased with increasing frailty, smoking, and vascular risk score.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Aspirin, Omega-3 Fatty Acid Supplementation and Adherence to aspirin, Treatment adherence, Adherence Predictors for Omega-3, and 1 more.
This study contributes evidence to
Primary intervention
Aspirin
Primary outcomes
Evidence topics
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
1
Related topics
4
Evidence pairs
45
Related studies
Evidence topic
Contributes evidence
Core evidence
The primary outcomes reported in this study.
Aspirin → Adherence to aspirin
Aspirin → Adherence to aspirin
Evidence profile
Aspirin → Treatment adherence
Aspirin → Treatment adherence
Evidence profile
Omega-3 Fatty Acid Supplementation → Adherence Predictors for Omega-3
Omega-3 Fatty Acid Supplementation → Adherence Predictors for Omega-3
Evidence profile
Omega-3 Fatty Acid Supplementation → Adherence to Omega-3
Omega-3 Fatty Acid Supplementation → Adherence to Omega-3
Evidence profile
Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.
Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Aspirin and Treatment Adherence, Omega-3 Fatty Acid Supplementation and Treatment Adherence.
This study contributes to the evidence on the following intervention-outcome relationships.
Curated evidence collections and hubs this study is part of.
All studies on Aspirin
Contributes to Aspirin evidence base.
All studies on Omega-3 Fatty Acid Supplementation
Contributes to Omega-3 Fatty Acid Supplementation evidence base.
All studies measuring Treatment Adherence
Measures Treatment Adherence as a key outcome.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in the evidence archive.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Aspirin appears to improve Adherence to aspirin.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Adherence to aspirin
EvidenceScore™ Emerging | EvidenceScore™ 55.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Omega-3 Fatty Acid Supplementation appears to improve Adherence to Omega-3.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Adherence to Omega-3
EvidenceScore™ Emerging | EvidenceScore™ 55.7 | strong positive | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Aspirin for Treatment adherence.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Treatment adherence
EvidenceScore™ Limited | EvidenceScore™ 38.1 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Omega-3 Fatty Acid Supplementation for Adherence Predictors for Omega-3.
ConsensusScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Adherence Predictors for Omega-3
EvidenceScore™ Limited | EvidenceScore™ 38.1 | neutral | ConsensusScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, archive views, and research summaries.
Open broader archive views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.